Chemical Process Operator

About the Position

CPL in partnership with SK pharmteco Ireland are looking for a Chemical Process Operator on a 12-month contract. The Chemical Process Operator is responsible for all tasks associated with the manufacture of Active Pharmaceutical Ingredients (API) and the operation of an API plant. This is a shift role working on a four-shift cycle supporting a 24/7/365 world-class manufacturing organisation.

Responsibilities

• Handling of chemicals to manufacture chemical intermediates and active pharmaceutical ingredients.
• Preparation and monitoring of equipment used for batch manufacturing and cleaning.
• Support Operational Excellence and other departmental projects as appropriate.
• Ensuring the plant is in an audit-ready state and that plant operations are executed in a safe manner and to expected cGMP standards.
• Participate on site emergency response team (if required).
• Use of business systems for carrying out real-time data entry and transactions for operations within the shift, e.g., SAP, IT & Delta V systems.
• Play a key role in meeting plant key performance indicators such as throughput, yield, safety, quality, and changeover targets.

Requirements

• Relevant qualification in Chemistry/Chemical Engineering/other science discipline or previous experience (4+ years) working within the pharmaceutical industry.
• API/small molecule experience a distinct advantage.
• Good interpersonal and communication skills, with a proven ability to troubleshoot and problem solve.
• Strong collaborative skills with an ability to work effectively in a team environment or on one’s own initiative without close supervision.

We Offer

• Opportunity to work in a state-of-the-art pharmaceutical manufacturing facility.
• Be part of a global Contract Development and Manufacturing organisation (CDMO) with facilities in Korea, US, France, and Ireland.
• Work with a talented workforce and exceptional technical capabilities.

About the Company

SK pharmteco is a global Contract Development and Manufacturing organisation (CDMO) with state-of-the-art facilities in Korea, US, France, and Ireland. We are part of SK Inc., a Korea company with revenues of $99 billion in 2023. Our mission is to ‘produce and deliver life-changing therapies that improve patient outcomes and save lives’. The SK pharmteco Small Molecule, Europe, facility located in Swords, Co Dublin, Ireland has led the way in the development, scale-up, and commercial manufacture of Active Pharmaceutical Ingredients (APIs) and Chemical Intermediates for over 60 years.

For further information on SK pharmteco, visit www.skpharmteco.com.